The “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely future evolution in this industry over the next ten years

Market-Research

To order this 450+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-09-11 08:31.

Over 80 firms are involved in providing antibody drug discovery-related services; whereas close to 125 players are offering antibody discovery platforms

Pharmaceuticals

According to experts in this field, the industry is investigating antibodies against novel targets which are expected to drive the market in the coming years. In fact, many service provider and platform provider companies are offering support to the medical research community in order to develop ... Read more

Submitted by Roots_Analysis on 2020-09-11 08:29.

The antibody discovery services and platforms market is projected to grow at an annualized rate of ~10%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030, covering key ... Read more

Submitted by Roots_Analysis on 2020-09-11 08:28.

The antibody discovery services market is estimated to be worth around USD 6.5 billion by 2030 instead the antibody discovery platforms market is anticipated to be worth close to USD 6 billion by 2030, predicts Roots Analysis

Pharmaceuticals

Antibody therapeutics have made it possible to address the hard to target hotspots, rendering the domain of antibody discovery an emerging sector in the pharmaceutical industry; in fact, the antibodies have proven to be promising weapons in the battle against COVID-19 pandemic. ... Read more

Submitted by Roots_Analysis on 2020-09-11 08:27.

Growing at an annualized rate of over 9%, the antibody discovery services market is projected to be worth USD 6.5 billion by 2030; the antibody discovery platforms market is estimated to be worth close to USD 6 billion by 2030: Roots Analysis

Pharmaceuticals

High target specificity and favorable safety profiles offered by antibody based pharmacological interventions has created a high demand for such molecules; the domain has witnessed an increased inflow of investments and collaboration opportunities.

Submitted by Roots_Analysis on 2020-09-11 08:26.

The ‘‘Drug Repurposing Service Providers Market, 2020-2030

Market-Research

Key Inclusions

A detailed assessment of the current market landscape of companies offering drug repurposing services based on several relevant parameters, including year of establishment, company size, location of headquarters, type of company, type of service

Submitted by Roots_Analysis on 2020-09-10 12:27.

Presently, over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry

Market-Research

Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development ... Read more

Submitted by Roots_Analysis on 2020-09-10 12:23.

The drug repurposing service providers market is projected to grow at an annualized rate of 14.7%, till 2030

Market-Research

Roots Analysis has done a detailed study on Drug Repurposing Service Providers Market, 2020-2030, covering key aspects of the industry’s evolution and ... Read more

Submitted by Roots_Analysis on 2020-09-10 12:20.

The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030

Market-Research

Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs

Submitted by Roots_Analysis on 2020-09-10 12:16.

The ‘Contract Regulatory Affairs Management Market for Medical Devices, 2019-2030’

Market-Research

Key Inclusions

A detailed review of the current market landscape of the medical devices regulatory affairs outsourcing market, featuring a list of over 400 CROs engaged in this domain, and detailed analysis based on a number of relevant parameters, such

Submitted by Roots_Analysis on 2020-09-10 12:12.

Over 400 companies claim to possess the required expertise to offer regulatory affairs management

Market-Research

More than 130 medical devices were approved by the FDA since January 2018, while several are currently being evaluated across more than 9,500 (active) clinical trials, worldwide. Even though technical innovation has enabled the development of a variety of versatile medical devices, product ... Read more

Submitted by Roots_Analysis on 2020-09-10 12:10.

The contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million

Market-Research

Roots Analysis has done a detailed study on Medical Device CROs for Regulatory Affairs Management Market, 2019-2030, covering key aspects of the

Submitted by Roots_Analysis on 2020-09-10 12:06.

The contract regulatory affairs-management services market for medical devices

Market-Research

Over the years, outsourcing has become a popular trend with the medical device industry, allowing innovators to leverage the technical and regulatory expertise of contract service providers in order to expedite time to market

Submitted by Roots_Analysis on 2020-09-10 12:02.